Life science startup Limula has raised $6.8 million to take its solution for automating cell therapy manufacturing to the ...

A new report from Graphite Digital has revealed that 36% of senior leaders in pharma agree that funding is the biggest ...

AstraZeneca’s Fasenra (benralizumab) has recently been approved by the FDA for treating severe asthma in children aged 6 to ...

CRISPR licensing company ERS Genomics and drug discovery firm IRBM have entered into a non-exclusive CRISPR/Cas9 license ...

At the ASCT 2024 conference a few weeks ago, Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, ...

Endeavor BioMedicines, a clinical-stage biotech company, has announced promising phase 2a trial results for its lead ...

Closed Loop Medicine, a techbio company specializing in personalized drug-plus-software therapies, and Pharmanovia, a global ...

Oxford BioDynamics (OBD) and King’s College London (KCL) have partnered to use OBD’s EpiSwitch technology to identify ...

In this interview, we delve into the world of bioprocessing with Himanshu Gadgil, the CEO of Enzene Biosciences.

Life sciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for ...

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head ...

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, ...